CalciMedica Quote - CALC

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

2.51

Bid

2.40

Offer

2.67

Volume

16,608

2.49 Day's Range 2.66

2.05 52 Week Range 6.265

Market Cap

33.84M

Previous Close

2.67

Open

2.66

Last Trade

2.4

Last Trade Time

Financial Volume

US$ 43,259

VWAP

2.6047

Average Volume (3m)

44,658

Shares Outstanding

13,481,917

Dividend Yield

PE Ratio

-0.98

Earnings Per Share (EPS)

-2.55

Revenue

Net Profit

-34.36M

CalciMedica, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for life-threatening inflammatory diseases with high unmet needs. Its technology targets the inhibition of Calcium Release-Activated Calcium (CRAC) channels designed to modulate the immune... CalciMedica, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for life-threatening inflammatory diseases with high unmet needs. Its technology targets the inhibition of Calcium Release-Activated Calcium (CRAC) channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases. CRAC channels serve to replenish calcium levels in the endoplasmic reticulum (ER) and provide calcium for cellular signaling events. Its lead product candidate, Auxora, is an intravenous-formulated, small molecule CRAC channel inhibitor. Auxora has the capability to modulate the immune response and protect against tissue cell injury, addressing inflammatory diseases, such as acute pancreatitis (AP), asparaginase-associated acute pancreatitis (AAP), acute kidney injury (AKI), and acute hypoxemic respiratory failure. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.calcimedica.com

Headquarters

Wilmington, Delaware, USA

Founded

CalciMedica Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CALC. The last closing price for CalciMedica was US$2.67. Over the last year, CalciMedica shares have traded in a share price range of US$ 2.05 to US$ 6.265.

CalciMedica currently has 13,481,917 shares in issue. The market capitalisation of CalciMedica is US$36 million. CalciMedica has a price to earnings ratio (PE ratio) of -0.98.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.2	-7.38007380074	2.71	2.75	2.3675	16849	2.6604037	CS
4	-0.66	-20.8201892744	3.17	3.2208	2.32	33282	2.66683223	CS
12	-0.94	-27.2463768116	3.45	3.67	2.05	44658	2.90191333	CS
26	-1.88	-42.8246013667	4.39	5.97	2.05	49144	3.63745287	CS
52	-2.72	-52.0076481836	5.23	6.265	2.05	39962	3.90103053	CS
156	-13.87	-84.6764346764	16.38	16.38	1.17	17618	3.91444328	CS
260	-13.87	-84.6764346764	16.38	16.38	1.17	12088	3.91444328	CS

CALC - Frequently Asked Questions (FAQ)

What is the current CalciMedica share price?

The current share price of CalciMedica is US$ 2.51

How many CalciMedica shares are in issue?

CalciMedica has 13,481,917 shares in issue

What is the market cap of CalciMedica?

The market capitalisation of CalciMedica is USD 36M

What is the 1 year trading range for CalciMedica share price?

CalciMedica has traded in the range of US$ 2.05 to US$ 6.265 during the past year

What is the PE ratio of CalciMedica?

The price to earnings ratio of CalciMedica is -0.98

What is the reporting currency for CalciMedica?

CalciMedica reports financial results in USD

What is the latest annual profit for CalciMedica?

The latest annual profit of CalciMedica is USD -34.36M

What is the registered address of CalciMedica?

The registered address for CalciMedica is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the CalciMedica website address?

The website address for CalciMedica is www.calcimedica.com

Which industry sector does CalciMedica operate in?

CalciMedica operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
JTAIJet AI Inc	US$ 6.02 (133.33%)	101.64M
SRMSRM Entertainment Inc	US$ 0.6999 (95.50%)	248.48M
WRDWeRide Inc	US$ 31.4877 (83.39%)	20.57M
INLFINLIF Limited	US$ 16.27 (80.58%)	7.67M
MBRXMoleculin Biotech Inc	US$ 2.1201 (66.94%)	134.88M
BLACBellevue Life Sciences Acquisition Corporation	US$ 3.08 (-56.31%)	425.19k
BLACUBellevue Life Sciences Acquisition Corporation	US$ 3.36 (-52.68%)	5.21k
CSAICloudastructure Inc	US$ 19.0001 (-49.58%)	1.01M
NEXNNexxen International Ltd	US$ 10.30 (-49.16%)	160.99k
BSLKBolt Projects Holdings Inc	US$ 0.6626 (-46.13%)	13.07M
CNSPCNS Pharmaceuticals Inc	US$ 0.1415 (31.26%)	489.28M
MGOLMGO Global Inc	US$ 0.7176 (-15.08%)	417.31M
SRMSRM Entertainment Inc	US$ 0.6999 (95.50%)	254.39M
INTCIntel Corporation	US$ 23.60 (-2.20%)	230.26M
NVDANVIDIA Corporation	US$ 138.85 (2.63%)	194.99M